CagriSema in people living with obesity and cardiovascular diseases
- Trial ID:
- IRB-23-8138
- Athena Philis-Tsimikas, M.D.
Inclusion Criteria
Patients must:
- • Have had a stroke, a heart attack (myocardial infarction),
or have poor circulation (peripheral arterial disease)
• Be 55 years of age or older
• Be living with obesity (BMI = 30 kg/m2 )
• Be able to attend regular clinic visits and receive phone
calls over a period of 3 years
• Meet all other eligibility criteria
Exclusion Criteria
Patients must not:
- • Be pregnant, breastfeeding or plan to get pregnant during
the study period
Additional Info
Participants will be randomized (like the flip of a coin) to CagriSema plus standard of care or matched placebo plus standard of care. The study consists of a screening period to assess eligibility, a 156-week treatment period and a 7-week follow-up period. The total study duration is expected to be about 41 months.Contact Info:
- Isabel Garcia, RN
- garcia.maria6@scrippshealth.org
- 858-309-2602